Navigation Links
Cardium Reports on First Quarter 2008 Highlights and Financial Results
Date:5/9/2008

$(6,734,128) $(5,839,849)

Net loss per common share - basic

and diluted $(0.16) $(0.17)

Weighted average shares outstanding

- basic and diluted 42,709,247 34,362,080

Selected Condensed March 31, December 31,

Consolidated Balance Sheet 2008 2007

(unaudited) (audited)

Cash and cash equivalents $6,300,638 $7,722,816

Accounts receivable, net 311,837 565,613

Inventories, net 1,337,870 1,037,164

Prepaid expenses and other current

assets 657,820 522,067

Property and equipment, net 1,644,416 1,650,632

Patented technology and intangibles,

net 4,568,916 4,766,330

Other long-term assets 748,023 661,067

Total assets $15,569,520 $16,925,689

Total current liabilities $5,545,073 $5,255,392

Long-term liabilities 2,849,334 3,241,992

Stockholder's equity 7,175,113 8,428,305

Total liabilities and stockholder's

equity $15,569,520 $16,925,689


'/>"/>
SOURCE Cardium Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
2. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
3. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
4. Cardiums Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
5. Cardium Completes $5.3 Million Registered Direct Offering
6. Cardium Announces $5.3 Million Registered Direct Offering
7. Novavax Reports First Quarter 2008 Financial Results
8. Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance
9. Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results
10. Pharmos Corporation Reports 2008 First Quarter Results
11. Halozyme Therapeutics Reports 2008 First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Denver, CO (PRWEB) July 29, 2014 ... and soiled linen collection and transport solutions for hospitals, ... Society for Healthcare Engineering (ASHE) Annual Conference & Technical ... TransVac will present its technology for making hospitals cleaner, ... operational costs over the hospital’s life cycle. Staff ...
(Date:7/29/2014)... , July 29, 2014  Sigma-Aldrich Corporation (NASDAQ: ... energy use, increased its investment in Green Chemistry and ... the world last year, the Company announced Monday in ... Science Changed the World? The report ... honors for being a responsible corporate citizen, including recognition ...
(Date:7/29/2014)... July 29, 2014 G-CON Manufacturing Inc., ... cleanrooms, today announced a new leadership appointment designed to ... States and abroad. , Maik Jornitz, Chief Operating ... company’s President charged with leading the pioneering company through ... enter this stage of development and look forward to ...
(Date:7/29/2014)... Dr. Jason Wendel – recipient of a ... of the Top 10 Plastic Surgeon Specialists for Nashville, TN ... His complete line includes a Hydration Booster, Retexturing Night Crème, ... and skin a younger, more radiant appearance while protecting them ... different, that is why at Dr. J. J. Wendel Plastic ...
Breaking Biology Technology:TransVac Presents Cost Saving Technology at ASHE Conference for Keeping Hospitals Cleaner 2Sigma-Aldrich Achieves Record Success in Environmental, Community Initiatives 2Sigma-Aldrich Achieves Record Success in Environmental, Community Initiatives 3G-CON Manufacturing, Inc. Announces Maik Jornitz as President 2Dr. J. J. Wendel Launches New Line of Skin Care Products 2
... 30, 2011 Merrimack Pharmaceuticals, Inc. announced today ... an oligoclonal therapeutic consisting of a mixture of ... encapsulation of irinotecan, at the 14th World Conference ... 7, 2011, in Amsterdam, The Netherlands. ...
... 29, 2011 Dendreon Corporation (Nasdaq: ... and Drug Administration (FDA) approved its Los Angeles cancer ... increase the availability of PROVENGE ® (sipuleucel-T) across ... with asymptomatic or minimally symptomatic metastatic castrate resistant (hormone ...
... Olive Branch Fund: A Thisbe and Noah Scott Legacy, ... today announced its first funding award to Kevin Eggan, ... at Harvard University.  The award will support Dr. Eggan,s ... that affect it.  Dr. Eggan is a leading researcher ...
Cached Biology Technology:Merrimack Announces Presentation of Preclinical Data at the 14th World Conference on Lung Cancer 2FDA Approves Dendreon's Los Angeles Cancer Immunotherapy Manufacturing Facility 2FDA Approves Dendreon's Los Angeles Cancer Immunotherapy Manufacturing Facility 3FDA Approves Dendreon's Los Angeles Cancer Immunotherapy Manufacturing Facility 4The Olive Branch Fund Announces Funding Award to Harvard Researcher 2
(Date:7/29/2014)... book that brings together two of the major disciplines ... of insect fossils through stunning photographs and unique illustrations. ... E Jepson, details the incredible preservation and diversity of ... for what these remarkable fossils can tell us about ... of our planet. Like the mosquito in Jurassic Park, ...
(Date:7/28/2014)... 100 drugs already approved by the U.S. Food and ... the growth of certain bacterial pathogens inside human cells, ... spotted fever. The findings, published in mBio , ... Microbiology, demonstrate a new way of identifying non-antibiotic drugs ... , A handful of drugs on the list inhibit ...
(Date:7/28/2014)... States have a circulatory problem of the legs called ... even require surgery in serious cases. This disease can ... limb amputation. , At The University of Texas Health ... a non-surgical preventative treatment in a mouse model of ... circulation. Their proof-of-concept study appears in the journal ...
Breaking Biology News(10 mins):Unique images bring fossil insects back to life 2New route to identify drugs that can fight bacterial infections 2Scientists discover genetic switch that can prevent peripheral vascular disease in mice 2
... pollution from power plants and automobiles is destroying the ... pollinating insects to follow scent trails to their source, ... partially explain why wild populations of some pollinators, particularly ... declining in several areas of the world, including California ...
... may be so old that dinosaurs once lumbered along its ... of Colorado at Boulder and the California Institute of Technology. ... to show the Grand Canyon may have formed more than ... 40 million to 50 million years. The researchers gathered ...
... Researchers from all over the world have been ... mouth and saliva cells to carry out the DNA analysis., ... (director of the Laboratory of Genetic Identification of the ... by the court in cases of paternity tests, for the ...
Cached Biology News:Flowers' fragrance diminished by air pollution, University of Virginia study indicates 2Grand Canyon may be as old as dinosaurs, says new study 2Grand Canyon may be as old as dinosaurs, says new study 3Fraud attempt in a paternity test modifies action protocol in DNA tests 2
... by John M. Walker (1996) • ... analytical techniques for studying proteins and ... contains detailed, step-by-step instruction, timesaving troubleshooting ... comprehensive lists of reagents and suppliers. ...
...
ANTI S. ENT TOX BC2D...
Reacts with MBP from human, bovine and rat, epitope 129-138. Reacts weakly with rabbit. Does not react with guinea pig....
Biology Products: